+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AC Immune SA - logo
Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030 - Product Thumbnail Image

Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 2055 Pages
  • Global
From
Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase) - Product Thumbnail Image

Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase)

  • Report
  • October 2022
  • 200 Pages
  • Global
From
Alzheimer's Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023-2030 - Product Thumbnail Image

Alzheimer's Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023-2030

  • Report
  • June 2023
  • 103 Pages
  • Global
From
Global Alzheimer's Disease Diagnostics & Therapeutics Market by Product (Diagnostics, Therapeutics), Disease Stage (Early, Moderate, Severe), End-User - Forecast 2023-2030 - Product Thumbnail Image

Global Alzheimer's Disease Diagnostics & Therapeutics Market by Product (Diagnostics, Therapeutics), Disease Stage (Early, Moderate, Severe), End-User - Forecast 2023-2030

  • Report
  • October 2023
  • 198 Pages
  • Global
From
Global Alzheimer's Therapeutics Market by Drug Class (Cholinesterase Inhibitors, NMDA [N-methyl-D-aspartate] Receptor Antagonist), Type (Medication, NMDA Receptor Antagonist), Distribution - Forecast 2023-2030 - Product Thumbnail Image

Global Alzheimer's Therapeutics Market by Drug Class (Cholinesterase Inhibitors, NMDA [N-methyl-D-aspartate] Receptor Antagonist), Type (Medication, NMDA Receptor Antagonist), Distribution - Forecast 2023-2030

  • Report
  • October 2023
  • 184 Pages
  • Global
From
Global Alzheimer's Disease Drugs Market by Drug Class (Cholinergic, Combined Drug, Memantine), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Forecast 2023-2030 - Product Thumbnail Image

Global Alzheimer's Disease Drugs Market by Drug Class (Cholinergic, Combined Drug, Memantine), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Forecast 2023-2030

  • Report
  • October 2023
  • 194 Pages
  • Global
From
Alzheimer Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Alzheimer Drugs Market - Forecast (2022 - 2027)

  • Report
  • February 2022
  • 111 Pages
  • Global
From
Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis - Product Thumbnail Image

Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • January 2023
  • 125 Pages
  • Global
From
Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • March 2019
  • 220 Pages
  • Global
From
Alzheimer's Disease Treatment Global Market Report 2023 - Product Thumbnail Image

Alzheimer's Disease Treatment Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics - Product Thumbnail Image

Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

  • Report
  • March 2020
  • 357 Pages
  • Global
From
Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 347 Pages
  • Global
From
Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2023 - Product Thumbnail Image

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2023

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
  • Global
From
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • November 2022
  • 330 Pages
  • Global
From
Alzheimer's Disease Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Alzheimer's Disease Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 1130 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 650 Pages
  • Global
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Loading Indicator